Abstract
One of two cases of endogenous Aspergillus endophthalmitis in abusers of intravenously administered drugs was treated successfully by subtotal pars plana vitrectomy; amphotericin B administered by intravitreal, periocular, and systemic routes; and flucytosine administered systemically. Aspergillus sp should be considered a possible pathogenic organism in drug abusers with endogenous endophthalmitis. An aggressive diagnostic and therapeutic approach may result in preservation of useful vision.
Publication types
-
Case Reports
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Adult
-
Amphotericin B / administration & dosage
-
Aspergillosis / diagnosis*
-
Aspergillosis / drug therapy
-
Aspergillosis / microbiology
-
Endophthalmitis / drug therapy
-
Endophthalmitis / etiology*
-
Endophthalmitis / microbiology
-
Female
-
Flucytosine / therapeutic use
-
Humans
-
Microbiological Techniques
-
Substance-Related Disorders / complications*
-
Visual Acuity
-
Vitreous Body / surgery
Substances
-
Amphotericin B
-
Flucytosine